Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
25.18
+0.49 (1.98%)
At close: May 1, 2026, 4:00 PM EDT
25.30
+0.12 (0.48%)
After-hours: May 1, 2026, 6:41 PM EDT
Alumis Employees
As of December 31, 2025, Alumis had 224 total employees, including 221 full-time and 3 part-time employees. The number of employees increased by 54 or 31.76% compared to the previous year.
Employees
224
Change
54
Growth
31.76%
Revenue / Employee
$107,366
Profits / Employee
-$1,086,272
Market Cap
3.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Sep 30, 2025 | 223 | 76 | 51.70% | 221 | 2 |
| Jun 30, 2025 | 227 | 97 | 74.62% | 225 | 2 |
| Mar 31, 2025 | 184 | 75 | 68.81% | 182 | 2 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Sep 30, 2024 | 147 | 38 | 34.86% | 145 | 2 |
| Jun 30, 2024 | 130 | - | - | 128 | 2 |
| Mar 31, 2024 | 109 | - | - | 107 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
| Tango Therapeutics | 137 |
| Erasca | 103 |
| NewAmsterdam Pharma Company | 100 |
ALMS News
- 4 weeks ago - Alumis Transcript: Study update - Transcripts
- 4 weeks ago - Alumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis - GlobeNewsWire
- 6 weeks ago - Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 6 weeks ago - Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 7 weeks ago - Alumis Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Alumis to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Alumis Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Alumis Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts